Celldex Therapeutics shares owned by AlphaCentric Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by AlphaCentric Advisors
from 13F filings
Historical chart of AlphaCentric Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by AlphaCentric Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.6M | 39k | 41.97 |
| 2023-09-30 | $413k | 15k | 27.52 |
| 2023-06-30 | $509k | 15k | 33.93 |
| 2023-03-31 | $540k | 15k | 35.98 |
| 2022-12-31 | $669k | 15k | 44.57 |
| 2022-09-30 | $478k | 17k | 28.12 |
| 2021-12-31 | $657k | 17k | 38.65 |
| 2021-09-30 | $918k | 17k | 54.00 |
| 2021-06-30 | $836k | 25k | 33.44 |
| 2021-03-31 | $515k | 25k | 20.60 |
| 2020-12-31 | $61k | 3.5k | 17.43 |
| 2020-09-30 | $52k | 3.5k | 14.86 |